Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$58.92 - $84.67 $1.04 Million - $1.49 Million
-17,617 Reduced 78.9%
4,710 $292,000
Q2 2022

Aug 15, 2022

BUY
$79.4 - $116.36 $1.2 Million - $1.75 Million
15,066 Added 207.49%
22,327 $1.78 Billion
Q1 2022

May 16, 2022

SELL
$86.42 - $109.81 $338,593 - $430,235
-3,918 Reduced 35.05%
7,261 $764 Million
Q4 2021

Feb 14, 2022

BUY
$98.56 - $119.91 $389,016 - $473,284
3,947 Added 54.58%
11,179 $1.21 Billion
Q3 2021

Nov 15, 2021

BUY
$91.91 - $110.37 $329,037 - $395,124
3,580 Added 98.03%
7,232 $792 Million
Q1 2021

May 14, 2021

SELL
$71.83 - $95.48 $817,209 - $1.09 Million
-11,377 Reduced 75.7%
3,652 $336,000
Q4 2020

Feb 12, 2021

BUY
$67.0 - $84.39 $1.01 Million - $1.27 Million
15,029 New
15,029 $1.1 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Alpha Paradigm Partners, LLC Portfolio

Follow Alpha Paradigm Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Paradigm Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Paradigm Partners, LLC with notifications on news.